keyword
MENU ▼
Read by QxMD icon Read
search

Neurology Lancet

keyword
https://www.readbyqxmd.com/read/28414641/vascular-disease-and-neurodegeneration-advancing-together
#1
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
May 2017: Lancet Neurology
https://www.readbyqxmd.com/read/28327327/investing-in-autism-better-evidence-for-better-care
#2
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
April 2017: Lancet Neurology
https://www.readbyqxmd.com/read/28229880/the-human-brain-project-adjusting-the-flagship-s-course
#3
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
March 2017: Lancet Neurology
https://www.readbyqxmd.com/read/28185975/effect-of-geopolitical-forces-on-neurosurgical-training-in-sub-saharan-africa
#4
Kara E Dempsey, Mahmood M Qureshi, Solomon M Ondoma, Robert J Dempsey
BACKGROUND: The population of Sub-Saharan Africa suffers from a critical shortage and maldistribution of healthcare professionals, especially highlighted in surgical subspecialties such as neurosurgery. In light of the Lancet Report and the World Health Organization's directive to provide essential surgical care through the developing world, solutions need to be found to close this training and distribution gap. METHODS: Methods correcting the situation will only succeed if one understands the geopolitical forces which have shaped the distribution of healthcare in the region and continue to this day...
February 6, 2017: World Neurosurgery
https://www.readbyqxmd.com/read/28144796/clinical-predictors-and-differential-diagnosis-of-posterior-reversible-encephalopathy-syndrome
#5
Laetitia Della Faille, S Fieuws, W Van Paesschen
The aim of our study is to determine the clinical predictors and the differential diagnosis of posterior reversible encephalopathy syndrome (PRES) in patients presenting with acute neurological symptoms and risk factors for PRES. Using the diagnostic algorithm for PRES from Fugate and Rabinstein (Lancet Neurol 14(9):914-925, 1), we carried out a retrospective study on 220 patients, presenting with acute neurological symptoms such as seizures, encephalopathy, headache, visual disturbances or other focal neurological signs that appear in the clinical setting of risk factors such as hypertension/blood pressure fluctuations, chemotherapy, renal failure, autoimmune disorders, or eclampsia, in whom imaging of the brain was performed to exclude PRES...
January 31, 2017: Acta Neurologica Belgica
https://www.readbyqxmd.com/read/28102152/solanezumab-too-late-in-mild-alzheimer-s-disease
#6
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
February 2017: Lancet Neurology
https://www.readbyqxmd.com/read/28090524/the-samukeppra-study-in-prehospital-status-epilepticus-lessons-for-future-study
#7
COMMENT
Andrew C Schomer, Jaideep Kapur
In the Lancet Neurology article "Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial" the authors conducted a prehospital, randomized controlled study to determine which treatment is more effective for status epilepticus (SE): benzodiazepine alone, or in combination with levetiracetam (LEV). Although the study had negative results, several aspects of the trial design likely masked any added effect that LEV may have had in controlling SE, including: higher doses of benzodiazepines, lower thresholds for determining cessation of SE, and a smaller sample size...
December 2016: Annals of Translational Medicine
https://www.readbyqxmd.com/read/27979337/rare-advances-for-rare-diseases
#8
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
January 2017: Lancet Neurology
https://www.readbyqxmd.com/read/27751534/lrrk2-and-the-new-era-of-parkinson-s-disease-research
#9
The Lancet Neurology
No abstract text is available yet for this article.
November 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27647632/the-relevance-of-good-research-reporting
#10
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
October 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27638428/curcumin-the-golden-nutraceutical-multitargeting-for-multiple-chronic-diseases
#11
REVIEW
Ajaikumar B Kunnumakkara, Devivasha Bordoloi, Ganesan Padmavathi, Javadi Monisha, Nand Kishor Roy, Sahdeo Prasad, Bharat B Aggarwal
Curcumin, a yellow pigment in the Indian spice Turmeric (Curcuma longa), which is chemically known as diferuloylmethane, was first isolated exactly two centuries ago in 1815 by two German Scientists, Vogel and Pelletier. However, according to the pubmed database, the first study on its biological activity as an antibacterial agent was published in 1949 in Nature and the first clinical trial was reported in The Lancet in 1937. Although the current database indicates almost 9000 publications on curcumin, until 1990 there were less than 100 papers published on this nutraceutical...
September 17, 2016: British Journal of Pharmacology
https://www.readbyqxmd.com/read/27566615/study-of-the-anti-seizure-effects-of-low-frequency-stimulation-following-kindling-a-review-of-the-cellular-mechanism-related-to-the-anti-seizure-effects-of-low-frequency-electrical-stimulation
#12
REVIEW
Zohreh Ghotbeddin, Mahyar Janahmadi, Ali Yadollahpour
Epilepsy affects about 1-2 % of world population as a chronic neurological disease that is manifested by repeated and consecutive seizures (Grone and Baraban, Nat Neurosci 18(3):339-343, 2015). There is no definitive therapy for epilepsy and antiepileptic drugs cannot offer a permanent and definitive cure for epilepsy, and most epileptic patients become drug resistant (Sasa, J Pharmacol Sci 100(5):487-494, 2006). Surgery and removal of the epileptic focus is a substitute method for treating drug-resistant patients and epilepsy surgery of either side of the brain improves seizure control...
January 2017: Neurological Sciences
https://www.readbyqxmd.com/read/27478943/the-shared-burden-of-stroke-and-dementia
#13
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
August 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27448714/neurology-in-the-aftermath-of-brexit
#14
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
September 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27302342/dementia-in-down-s-syndrome-still-much-to-learn
#15
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
July 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27302221/finding-a-cure-for-alzheimer-s-disease-starts-with-prevention
#16
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
June 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27302112/a-persistent-pain
#17
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
May 2016: Lancet Neurology
https://www.readbyqxmd.com/read/27209143/the-burden-of-mental-neurological-and-substance-use-disorders-in-china-and-india-a-systematic-analysis-of-community-representative-epidemiological-studies
#18
REVIEW
Fiona J Charlson, Amanda J Baxter, Hui G Cheng, Rahul Shidhaye, Harvey A Whiteford
BACKGROUND: China and India jointly account for 38% of the world population, so understanding the burden attributed to mental, neurological, and substance use disorders within these two countries is essential. As part of the Lancet/Lancet Psychiatry China-India Mental Health Alliance Series, we aim to provide estimates of the burden of mental, neurological, and substance use disorders for China and India from the Global Burden of Disease Study 2013 (GBD 2013). METHODS: In this systematic analysis for community representative epidemiological studies, we conducted systematic reviews in line with PRISMA guidelines for community representative epidemiological studies...
July 23, 2016: Lancet
https://www.readbyqxmd.com/read/27040985/a-role-for-tenm1-mutations-in-congenital-general-anosmia
#19
A Alkelai, T Olender, R Haffner-Krausz, M M Tsoory, V Boyko, P Tatarskyy, R Gross-Isseroff, R Milgrom, S Shushan, I Blau, E Cohn, R Beeri, E Levy-Lahad, E Pras, D Lancet
Congenital general anosmia (CGA) is a neurological disorder entailing a complete innate inability to sense odors. While the mechanisms underlying vertebrate olfaction have been studied in detail, there are still gaps in our understanding of the molecular genetic basis of innate olfactory disorders. Applying whole-exome sequencing to a family multiply affected with CGA, we identified three members with a rare X-linked missense mutation in the TENM1 (teneurin 1) gene (ENST00000422452:c.C4829T). In Drosophila melanogaster, TENM1 functions in synaptic-partner-matching between axons of olfactory sensory neurons and target projection neurons and is involved in synapse organization in the olfactory system...
September 2016: Clinical Genetics
https://www.readbyqxmd.com/read/26922439/zika-virus-a-little-less-speculation-a-little-more-action
#20
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
April 2016: Lancet Neurology
keyword
keyword
98525
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"